Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$8.57 - $15.79 $6.5 Million - $12 Million
-757,891 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$4.65 - $8.73 $3.52 Million - $6.62 Million
757,891 New
757,891 $4.67 Million

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $515M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Windmill Hill Asset Management LTD Portfolio

Follow Windmill Hill Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windmill Hill Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Windmill Hill Asset Management LTD with notifications on news.